Literature DB >> 11063627

Hydrolytic stability versus ring size in lactams: implications for the development of lactam antibiotics and other serine protease inhibitors.

P Imming1, B Klar, D Dix.   

Abstract

beta-Lactam antibiotics act by acylating a serine hydroxyl group in the catalytic center of bacterial proteases. This requires, among other things, suitable reactivity of the lactam moiety. To evaluate the possible suitability of other lactam systems, kinetic studies were performed using the model reaction of lactams with hydroxide. Following the pace of the reaction by NMR, we found gamma-butyrolactam to be hydrolyzed considerably slower than beta-propiolactam. Surprisingly, delta-valerolactam and beta-propiolactam had the same reactivity. beta-Lactam antibiotics were more reactive than both by approximately a factor of 10(3). Medium-sized lactams were least susceptible to hydrolysis. The study highlights the as yet overlooked six-membered lactam ring as a promising vantage point for the development of new classes of antiinfectives and other serine protease inhibitors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063627     DOI: 10.1021/jm000921k

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.

Authors:  Thomas F Durand-Réville; Satenig Guler; Janelle Comita-Prevoir; Brendan Chen; Neil Bifulco; Hoan Huynh; Sushmita Lahiri; Adam B Shapiro; Sarah M McLeod; Nicole M Carter; Samir H Moussa; Camilo Velez-Vega; Nelson B Olivier; Robert McLaughlin; Ning Gao; Jason Thresher; Tiffany Palmer; Beth Andrews; Robert A Giacobbe; Joseph V Newman; David E Ehmann; Boudewijn de Jonge; John O'Donnell; John P Mueller; Rubén A Tommasi; Alita A Miller
Journal:  Nat Microbiol       Date:  2017-06-30       Impact factor: 17.745

2.  Dicarboxylic Acid Monoesters in β- and δ-Lactam Synthesis.

Authors:  Anna Ananeva; Olga Bakulina; Dmitry Dar'in; Grigory Kantin; Mikhail Krasavin
Journal:  Molecules       Date:  2022-04-11       Impact factor: 4.927

3.  Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine.

Authors:  Tika R Malla; Lennart Brewitz; Dorian-Gabriel Muntean; Hiba Aslam; C David Owen; Eidarus Salah; Anthony Tumber; Petra Lukacik; Claire Strain-Damerell; Halina Mikolajek; Martin A Walsh; Christopher J Schofield
Journal:  J Med Chem       Date:  2022-05-12       Impact factor: 8.039

4.  Defeating Bacterial Resistance and Preventing Mammalian Cells Toxicity Through Rational Design of Antibiotic-Functionalized Nanoparticles.

Authors:  Jessica Fernanda Affonso de Oliveira; Ângela Saito; Ariadne Tuckmantel Bido; Jörg Kobarg; Hubert Karl Stassen; Mateus Borba Cardoso
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

5.  Investigations on recyclisation and hydrolysis in avibactam mediated serine β-lactamase inhibition.

Authors:  Hwanho Choi; Robert S Paton; Hwangseo Park; Christopher J Schofield
Journal:  Org Biomol Chem       Date:  2016-04-26       Impact factor: 3.876

Review 6.  Development of new drugs for an old target: the penicillin binding proteins.

Authors:  Astrid Zervosen; Eric Sauvage; Jean-Marie Frère; Paulette Charlier; André Luxen
Journal:  Molecules       Date:  2012-10-24       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.